Novel compositions are disclosed for use in the treatment or diagnosis of bovine pasteurellosis, commonly referred to as Shipping Fever. Cell-free Pasteurella haemolytica supernatants are employed to provide individual antigen compositions, identified through reaction with sera from naturally-infected or convalescent cattle. In particular, at least seven individual P. hameolytica antigen groups were recognized in cell-free culture supernatants. Purified P. haemolytica supernatant, formulated in a suitable pharmaceutical vaccine composition is shown to elicit a specific immune response, in both cows and rabbits, directed against the individual immunoreactive P. haemolytica polypeptides identified. Also disclosed are novel recombinant cells, plasmids and bacteriophage which include transcriptionally active P. haemolytica antigen genes. Recombinant clones are similarly selected to be reactive with naturally-infected antisera. Examples, and further disclosure, are also provided which demonstrate the utility of a presently disclosed antibody and antigen compositions in immunodetection of both antigens and antibodies in various biological samples.
本发明揭示了用于治疗或诊断牛传染性败血症(通常称为运输热)的小说组合物。利用无
细胞培养基上清液提供单个抗原组合物,通过与自然感染或康复牛血清反应鉴定。特别地,在无
细胞培养基上清液中识别出至少七个单独的P. hameolytica抗原组。经过纯化的P. haemolytica上清液,配制成适当的制药疫苗组合物,被证明能够在奶牛和兔子中引起特异性免疫反应,针对已经鉴定出来的单个免疫反应性P. haemolytica
多肽。此外,本发明还揭示了包括转录活性P. haemolytica抗原
基因的新型
重组细胞、质粒和噬菌体。
重组克隆同样被选中与自然感染抗血清反应。本发明还提供了例子和进一步的披露,证明了目前披露的
抗体和抗原组合物在各种
生物样本中的免疫检测中的效用。